FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat

cryptocurrency 1 week ago
Flipboard
French drugmaker Sanofi SA (NASDAQ:SNY) and its partner Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) on Wednesday secured U.S. Food and Drug …
Read Entire Article